Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. APO
7. TLT
8. BETR
9. AMZN
10. LEN

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 17.19 -0.34 (1.94%)
Previous Close $17.53    52 Week High $12.48 
Open $17.72    52 Week Low $1.60 
Day High $17.72    P/E N/A 
Day Low $16.93    EPS $-6.33 
Volume 785,609